Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141209020258N83Phase 3Completed
Phase 3, double-blind trial of dexmedetomidine, tramadol, neostigmine and lidocaine in postoperative pain (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean narcotic drug use during the first 24 hours after surgery, Duration of analgesia and 4 more. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141209020258N83.